POMC and primary aldosteronism: In this randomized clinical trial including 228 patients with primary aldosteronism in China, the proportion of patients with complete biochemical remission at follow-up was 51.3% for AVS without and 49.6% for AVS with ACTH stimulation, not a statistically significant difference.